Sulfadoxine-pyrimethamine resistant malaria from west or central Africa.
作者信息
Gubler J
出版信息
Br Med J (Clin Res Ed). 1988 Feb 6;296(6619):433. doi: 10.1136/bmj.296.6619.433-a.
Abstract
摘要
相似文献
1
Sulfadoxine-pyrimethamine resistant malaria from west or central Africa.
Br Med J (Clin Res Ed). 1988 Feb 6;296(6619):433. doi: 10.1136/bmj.296.6619.433-a.
2
[Plasmodium falciparum drug resistance and sulfadoxine-pyrimethamine in Africa].
Bull Soc Pathol Exot Filiales. 1989;82(3):381-4.
3
A case of Plasmodium falciparum infection resistant to chloroquine.
Ethiop Med J. 1987 Oct;25(4):209-10.
4
Chloroquine resistance in Plasmodium falciparum in KwaZulu, 1983-1988.
S Afr Med J. 1989 Nov 18;76(10):546-7.
5
[Resistance of Plasmodium falciparum in the Brazilian Amazonas to the combination of sulfadoxine and pyrimethamine].
Rev Inst Med Trop Sao Paulo. 1982 Nov-Dec;24(6 Suppl):44-7.
6
[Unsuccessful effect of sulfadoxine-pyrimethamine in the treatment of falciparum malaria in Tanzania].
Ugeskr Laeger. 1983 Mar 7;145(10):751.
7
[In vivo resistance of Plasmodium falciparum to the combination of sulfadoxine and pyrimethamine, at RIII level, in Amazonas, Brazil].
Rev Inst Med Trop Sao Paulo. 1982 Nov-Dec;24(6 Suppl):52-3.
8
Extension of multiple drug resistant Plasmodium falciparum malaria in Africa: report of a Central African case.
Biomed Pharmacother. 1989;43(9):699-702. doi: 10.1016/0753-3322(89)90090-5.
9
[A case of malaria tropicameningoencephalitis (neuromalaria) with chloroquine and pyrimethamine/sulfadoxine resistance].
Nervenarzt. 1985 Feb;56(2):101-5.
10
Concurrent chloroquine- and Fansidar-resistant Plasmodium falciparum: an imported case into Zimbabwe.
J Trop Med Hyg. 1986 Oct;89(5):265-8.
引用本文的文献
1
In vitro activities of novel antifolate drug combinations against Plasmodium falciparum and human granulocyte CFUs.
Antimicrob Agents Chemother. 1995 Apr;39(4):948-52. doi: 10.1128/AAC.39.4.948.
2
Treatment of malaria--1990.
Drugs. 1990 Feb;39(2):160-89. doi: 10.2165/00003495-199039020-00002.
3
The disposition of oral and intramuscular pyrimethamine/sulphadoxine in Kenyan children with high parasitaemia but clinically non-severe falciparum malaria.
Br J Clin Pharmacol. 1992 Feb;33(2):143-8. doi: 10.1111/j.1365-2125.1992.tb04016.x.
4
Treatment and prevention of falciparum malaria in Africa.
J R Coll Physicians Lond. 1992 Oct;26(4):445-9.
本文引用的文献
1
Plasma concentrations in pyrimethamine and sulfadoxine and evaluation of pharmacokinetic data by computerized curve fitting.
Bull World Health Organ. 1982;60(1):115-22.
2
Possible role of drug malabsorption in recrudescence of falciparum malaria.
Lancet. 1982 Nov 20;2(8308):1157-8. doi: 10.1016/s0140-6736(82)92807-0.
3
The susceptibility of Plasmodium falciparum to sulfadoxine and pyrimethamine: correlation of in vivo and in vitro results.
Am J Trop Med Hyg. 1986 Mar;35(2):239-45. doi: 10.4269/ajtmh.1986.35.239.
4
Evaluation of an in vitro test method for the assessment of sensitivity of Plasmodium falciparum to pyrimethamine and sulfadoxine.
Bull World Health Organ. 1987;65(3):345-52.
Zotero 插件